Dophabrex 125
Basic Information
Category
Subcategory & Sub-subcategory
/
Trade Type
Sell
Product Name
Dophabrex 125
Details
Substance
Manufacturer(s)
- -
Registered Market
Specifications
- Dosage Form: Powder reconstituted as suspension oral
- Packaging: Box 1 vial x 65 g, for reconstitution as 100 mL suspension; box 1 vial x 78 g, for reconstitution as 120 mL suspension; box 1 vial x 39 g, for reconstitution as 60 mL suspension; box 1 vial x 19,5 g, for reconstitution as 30 mL suspension
- Standards: In-house standard
- Shelf Life: 36 month
Documents
Drug Marketing Authorization Number
Document No.: 893110819524
Issue Date: Aug 22, 2024
Expiry Date: Aug 22, 2029
Note: 607/QĐ-QLD | 208
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment